invoX Pharma

Just over a decade after Simon Westbrook bought a promising non-addictive he had developed from former employer Pfizer Inc. , the company he formed – Levicept Ltd – has posted promising mid-stage da

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Takeda, F-star Sign Joint Research Pact

The Chinese major Sino Biopharmaceutical Limited has completed a $161m all-cash acquisition of UK biotech F-star Therapeutics, Inc. after finally reaching an agreement with the US Committee on For

Biopharma Acquisitions Biopharma merger and acquisition value for the second quarter of 2022 reached $25.4bn from 36 transactions, 20 of which had disclosed values. Four M&A transactions hit or exceed